Shockwave Medical, a $237m developer of technologies treating calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve disease, is acquiring Neovasc, a $2.5m Canada-based developer of transcatheter devices treating refractory angina and mitral valve disease. Deal terms – $100m upfront plus $47m in milestones...
Read More
Zimmer Biomet Holdings, Inc., a $8.0b maker of orthopedic reconstructive products is acquiring Embody, Inc., a developer of collagen implants for repairing tendons, ligaments and torn rotator cuffs. The acquisition builds Zimmer Biomet’s sports medicine offerings after it spun-off its dental and spine operations into Zimvie, a separate,...
Read More
The Walden Group is pleased to announce that it represented Total Titanium, Inc. (TTI) in its sale to a subsidiary of Bausch + Lomb Corporation (NYSE/TSX:BLCO) (“Bausch + Lomb”). TTI was one of the last remaining independently-owned manufacturers of precision ophthalmic instruments based in the United States. Bausch + Lomb is a leading global...
Read More
The Walden Group is pleased to provide access to its Q3 2022 Strategic Healthcare M&A Report, which includes:
Market Overview -- What you need to know about MDR and more
Major M&A Deals by Sector
For Ophthalmology, Orthopedic & Spine, and Woundcare - Key Developments and Deals
Key Stats on Top...
Read More
Aspen Surgical, a producer of disposable surgical products and a portfolio company of Audax Group, has purchased Symmetry Surgical, a maker of electrosurgery products, instruments and minimally invasive surgical devices, from Roundtable Healthcare Partners. The acquisition diversifies Aspen’s offerings into electrosurgery including bipolar...
Read More